Home / Resources / Webinar / How to Succeed in a Transformational Med Tech Landscape: Regulatory, Evidence, and Communication Strategies Symposium

How to Succeed in a Transformational Med Tech Landscape: Regulatory, Evidence, and Communication Strategies Symposium

Live webinar


  1. New Trends in the Regulatory Setting
  2. Evidence Needs to Enable Uptake
  3. Payer & Key Stakeholder Engagement

This symposium will be a virtual event with three live presentations featuring Certara’s device specialists in regulatory, real-world evidence generation and scientific communication.  It will explore the latest trends transforming the medical technology landscape and how they have affected regulatory approvals and market access. Specifically covered will be how and the bar for evidence to show the value of the device has become paramount and how to leverage these data via optimal value communication tools.

To best inform our discussion, we’d love to receive your feedback in this short survey.


Thank you for Registering!

Certara Angela Siebeneck
Angela Siebeneck, MSN RN
Director, Regulatory Strategy and Policy
Ms. Siebeneck has over 30 years of clinical and device experience. She has written and provided guidance and advice for over 100 clinical evaluation reports for a wide variety of devices. During her career as a nurse she gained deep practical experience with many of the types of devices she has developed and implemented clinical evaluation strategies. She has even written a book on peripherally inserted central catheters (PICC) which provides details on how to insert and care for PICCs and ensure compliance with the recommendations for use.
Lee Stern
Lee Stern, MSc
Vice President, Global Head of Consulting Operations
Lee is responsible for all health economic and market access engagements for global clients. She also oversees the full operations of the New York office. Lee is a strategic and actionable leader managing highly qualified and scientifically robust cross-functional and geographically disparate teams.
Certara Wah Yan
Wah Yan
Director, Evidence and Access
Wah Yan is a Director as part of Certara’s Evidence & Access group. Wah joins from Novo Nordisk, where he spent four years supporting the development of the company’s long-term enterprise strategy. As a strategist, Wah continually tackles one of healthcare’s biggest challenges – how do you build sustainable business models in the face of accelerating change in US healthcare. He combines this perspective with Certara’s unique data capabilities & tech platforms to empower clients not only to lower the cost of innovation, but to maximize realized value from those investments.
Shawn Headshot
Shawn W. Bates
Vice President of Global Business Development
Shawn Bates joined Certara in summer 2020 for our BaseCase stakeholder engagement platform after gaining over 20 years’ experience working across the pharmaceutical and medical device industries. Having held a variety of senior leadership positions, his expertise lies in stakeholder engagement and management in the market access and medical affairs spaces.
Back to top